Sustained Improvement in Patient-Reported Outcomes with Continued Apremilast Treatment over 104 Weeks in Patients with Moderate to Severe Psoriasis. J of Skin [Internet]. 2018 Feb. 23 [cited 2026 May 22];2(S1):S23. Available from: https://skin.dermsquared.com/skin/article/view/267